France Genetic Testing Market to 2032
Overview
The France Genetic Testing Market is expected to reach a 3.63 USD Billion by 2032 and is projected to grow at a CAGR of 22.50% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.13
Forecast, 2032 (USD Billion)
3.63
CAGR, 2024 - 2032
22.50%
Report Coverage
France
France Genetic Testing Market 2018-2032 USD Billion
France Genetic Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.13 USD Billion
- Projected Market Size (2032): 3.63 USD Billion
- CAGR (2025-2032): 22.50%
Key Findings of France Genetic Testing Market
- The France Genetic Testing Market was valued at 1.13 USD Billion in 2024.
- The France Genetic Testing Market is likely to grow at a CAGR of 22.50% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cancer in Diseases Segment accounted for the largest share of the market with a revenue of 0.68 USD Billion
- The fastest growing segment Diagnostic Testing in Type Segment grew Fastest with a CAGR of 25.59% during the forecast period from 2024 to 2032.
France Genetic Testing Market Scope
France Genetic Testing Market Segmentation & Scope
End User
- Private Laboratories
- Laboratory Service Providers
- Private Clinics
- Diagnostic Centers
- Clinics
- Hospitals
Diseases
- Others
- Cystic Fibrosis
- Huntington's Disease
- Duchenne Muscular Dystrophy
- Fragile X Syndrome
- Rare Genetic Disorder
- Thalassemia
- Sickle Cell Anemia
- Cancer
Technology
- Others
- Fluorescence In Situ Hybridization (FISH)
- Microarrays
- Whole Genome Sequencing
- DNA Sequencing (NGS-Based Testing)
- Polymerase Chain Reaction
Type
- Other Types
- Carrier Testing
- Predictive and Presymptomatic Testing
- New Born Screening
- Prenatal Testing
- Diagnostic Testing
France Genetic Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.13 USD Billion |
| Market Value in 2032 | 3.63 USD Billion |
| CAGR (2025-2032) | 22.50% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Diseases,Technology,Type |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 1.13 USD Billion in 2024
- Key Country: France, leading in terms of revenue with value of 1,131.72 USD Million in 2024.
Segments and Scope
-
France Genetic Testing Market to 2032, By End User
- Hospitals is the largest segment in France Genetic Testing Market to 2032 with a revenue of 426.49 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in France Genetic Testing Market to 2032 with a Growth rate of 25.33 % in forecast period 2025-2032.
-
France Genetic Testing Market to 2032, By Diseases
- Cancer is the largest segment in France Genetic Testing Market to 2032 with a revenue of 678.23 USD Billion in the year 2024.
- Cancer is the Fastest growing segment in France Genetic Testing Market to 2032 with a Growth rate of 24.01 % in forecast period 2025-2032.
-
France Genetic Testing Market to 2032, By Technology
- Polymerase Chain Reaction is the largest segment in France Genetic Testing Market to 2032 with a revenue of 476.24 USD Billion in the year 2024.
- Polymerase Chain Reaction is the Fastest growing segment in France Genetic Testing Market to 2032 with a Growth rate of 25.09 % in forecast period 2025-2032.
-
France Genetic Testing Market to 2032, By Type
- Diagnostic Testing is the largest segment in France Genetic Testing Market to 2032 with a revenue of 441.60 USD Billion in the year 2024.
- Diagnostic Testing is the Fastest growing segment in France Genetic Testing Market to 2032 with a Growth rate of 25.59 % in forecast period 2025-2032.
France Genetic Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Cepheid | |||
| Fulgent Genetics | |||
France Genetic Testing Market Geographical Sales Distribution, 2018-2032 USD Billion
France Genetic Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Genetic Testing Market is segmented based on Segmentation End User,Diseases,Technology,Type.
France Genetic Testing Market was valued at USD 1.13(Revenue in USD Billion) in 2021.
France Genetic Testing Market is projected to grow at a CAGR of 22.50% during the forecast period of 2024 to 2032.
The Cancer segment is expected to dominate the France Genetic Testing Market, holding a largest market share of 0.68 USD Billion in 2024
France Genetic Testing Market Scope
France Genetic Testing Market Segmentation & Scope
End User
- Private Laboratories
- Laboratory Service Providers
- Private Clinics
- Diagnostic Centers
- Clinics
- Hospitals
Diseases
- Others
- Cystic Fibrosis
- Huntington's Disease
- Duchenne Muscular Dystrophy
- Fragile X Syndrome
- Rare Genetic Disorder
- Thalassemia
- Sickle Cell Anemia
- Cancer
Technology
- Others
- Fluorescence In Situ Hybridization (FISH)
- Microarrays
- Whole Genome Sequencing
- DNA Sequencing (NGS-Based Testing)
- Polymerase Chain Reaction
Type
- Other Types
- Carrier Testing
- Predictive and Presymptomatic Testing
- New Born Screening
- Prenatal Testing
- Diagnostic Testing
Frequently Asked Questions
The France Genetic Testing Market is segmented based on Segmentation End User,Diseases,Technology,Type.
France Genetic Testing Market was valued at USD 1.13(Revenue in USD Billion) in 2021.
France Genetic Testing Market is projected to grow at a CAGR of 22.50% during the forecast period of 2024 to 2032.
The estimated market value of the France Genetic Testing Market for final year is USD 3.63 (USD Billion).
France Genetic Testing Market Company Profiling
Frequently Asked Questions
The France Genetic Testing Market is segmented based on Segmentation End User,Diseases,Technology,Type.
France Genetic Testing Market was valued at USD 1.13(Revenue in USD Billion) in 2021.
France Genetic Testing Market is projected to grow at a CAGR of 22.50% during the forecast period of 2024 to 2032.
The estimated market value of the France Genetic Testing Market for final year is USD 3.63 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.